Cargando…
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response()
Over the last decade we have witnessed the convergence of two powerful experimental designs toward a common goal of defining the molecular subtypes that underpin the likelihood of a cancer patient responding to treatment in the clinic. The first of these ‘experiments’ has been the systematic sequenc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003351/ https://www.ncbi.nlm.nih.gov/pubmed/24607840 http://dx.doi.org/10.1016/j.gde.2013.12.002 |